either on their own or for taking along with a nasal spray. Surgery is only an option if the polyps are very large or if a person has not responded well to other treatments after around 12 weeks.

What you may think are allergies or a cold, could be the sign of nasal polyps. Nasal polyps are non-cancerous growths that line the nasal passages and sinuses. They are soft, painless, and hang ...

Sanofi and Regeneron’s Dupixent has had the US market for the treatment of chronic rhinosinusitis with nasal polyps (CRSwNP) mainly to itself since June 2019, but GlaxoSmithKline’s Nucala is ...

AstraZeneca has failed in its bid to get US approval for its IL-5 inhibitor Fasenra as a treatment for chronic rhinosinusitis in people with nasal polyps, after the FDA rejected its marketing ...

Blue Cross Blue Shield company Health Care Service Corporation is limiting access for in-office administration of asthma ...

When medications and conservative treatments fail, nasal polyp surgery becomes a vital option for relief. This minimally invasive procedure, known as functional endoscopic sinus surgery (FESS ...

When sinusitis does not respond to treatment, your doctor may recommend surgery to remove a polyp or nasal tissue.

GSK plc announced that the China National Medical Products Administration (NMPA) has approved Nucala (mepolizumab), a monoclonal antibody that targets interleukin-5 (IL-5), as an add-on therapy with ...

as an add-on treatment with intranasal corticosteroids to treat chronic rhinosinusitis with nasal polyps (CRSwNP) in the adult population. This marks the third indication for an interleukin-5 (IL ...